Monday, November 25, 2013

You get the blue pill, I get the yellow, and he gets the green; the future of customized medicine.

Imagine you went to the doctor with your brother; both of you are sick with the same thing, but they hand you a blue pill and him a yellow one. You both get better in record breaking time but if you had been given the yellow pill and him the blue, neither of you would be feeling any better a week later.
Customizing peoples’ healthcare based on their genetic data is the future of medicine. Driven by the Affordable Care Act, huge amounts of electronic data are being compiled. These human genomes are being coupled with other factors such as gut bacteria, drug treatments, skin bacteria, and their environments to produce petabytes of data of thousand of people that are hopefully going to show researchers a genomic trend. If they can start to find trends they can treat people specifically based on how they think the body will best react. The recovery information can be submitted as well and added to the data for more trend analysis.  Not only can sequencing someone’s genome help cure them, but it can also alert of preventative needs or who is more critically ill in need of service. Mount Sinai has already been doing this to help lower the 30-day readmission rate for patients by 56% percent, just by determining who was at the highest risk for returning to the hospital.  This type of work can save hospitals thousands of dollars by not distributing treatments that would not have worked for the patient.
The availability of genome sequencing is rising. To sequence a genome cost around three thousand dollars at the moment, but is quickly approaching the cost of an MRI or PET scan. However, if the data becomes available or accessed by the public, discrimination would occur. Employers would be less likely to hire someone with a health defect if they pay employees’ health insurance. It is crucial that this information is kept safer, since some has already leaked out. If those issues can be fixed then this is the future of medicine. We will be living in a world in which our genomic data will determine our prescription, our lifestyle, and our safety.

Kennedy, K. (2013, November 24). Analysis of huge data sets will reshape health care. Retrieved from http://www.usatoday.com/story/news/nation/2013/11/24/big-data-health-care/3631211/


1 comment:

  1. This is a really fascinating article, especially with completion of the human genome project, and could prove to be drastically change the way we see medicine. However, I have to ask if you found any research on how they are reducing the cost from three thousand dollars? Primarily since I expect that the equipment and data needed to precisely modify medicine is very complex and not cheap. Also, any thought on whether or not you believe that companies who provide healthcare for their employees should be allowed access to such private information? I think that definitely needs to be addressed before this can truly become reality since it could drastically impact job opportunity. Just curious to see what you and others might think about how this should be addressed?

    ReplyDelete